A Randomized Trial of Enhanced Therapy for Early Syphilis in Patients with and without Human Immunodeficiency Virus Infection
Open Access
- 31 July 1997
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 337 (5), 307-314
- https://doi.org/10.1056/nejm199707313370504
Abstract
Reports of neurosyphilis and invasion of cerebrospinal fluid by Treponema pallidum in patients with human immunodeficiency virus (HIV) infection have led to doubts about the adequacy of the recommended penicillin G benzathine therapy for early syphilis.Keywords
This publication has 34 references indexed in Scilit:
- Treatment of Syphilis, 1993Clinical Infectious Diseases, 1995
- Procedural guidelines for performing immunophenotyping by flow cytometryClinical Immunology and Immunopathology, 1989
- Report of the Workshop on the Evaluation of T-Cell Subsets during HIV Infection and AIDSClinical Immunology and Immunopathology, 1989
- Alteration in the Natural History of Neurosyphilis by Concurrent Infection with the Human Immunodeficiency VirusThe New England Journal of Medicine, 1987
- Syphilis in the AIDS EraThe New England Journal of Medicine, 1987
- Neurologic Relapse after Benzathine Penicillin Therapy for Secondary Syphilis in a Patient with HIV InfectionThe New England Journal of Medicine, 1987
- Clinical Manifestations of Secondary SyphilisInternational Journal of Dermatology, 1987
- Treatment of primary and secondary syphilis: defining failure at three- and six-month follow-upJAMA, 1987
- Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency SyndromeThe New England Journal of Medicine, 1983
- Treponemicidal Levels of Amoxicillin in Cerebrospinal Fluid After Oral AdministrationSexually Transmitted Diseases, 1983